# Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)

Study · id `cardio:ct-nct02194608` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02194608](<https://clinicaltrials.gov/study/NCT02194608>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02194608

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 500 participants.

## Technical summary

Registry record NCT02194608. Randomized; no masking. Start 2011-12 (registry gives no type); primary completion 2013-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking
- Phase: Not applicable
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT02194608, source copy `cardio:ctgov-nct02194608-2015-06-24`, retrieved 2026-10-26)
- Start date: 2011-12 (registry gives no type) (ClinicalTrials.gov record NCT02194608, source copy `cardio:ctgov-nct02194608-2015-06-24`, retrieved 2026-10-26)
- Primary completion: 2013-07 (actual) (ClinicalTrials.gov record NCT02194608, source copy `cardio:ctgov-nct02194608-2015-06-24`, retrieved 2026-10-26)
- Completion: 2013-07 (actual) (ClinicalTrials.gov record NCT02194608, source copy `cardio:ctgov-nct02194608-2015-06-24`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02194608-2015-06-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): Home telehealth system
- Lead sponsor: Merck Sharp & Dohme LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Merck Sharp & Dohme LLC (`cardio:org-merck-sharp-dohme-llc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes (`cardio:pubmed-26154338`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 6fc2d41695df4e1bc8e62a5bd911bbeb97cec6cae90281faa37c85c6772514f3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
